Any Beltran Anzola1,2, Vanessa Pauly3,4, Cendrine Geoffroy-Siraudin5, Marie-José Gervoise-Boyer5, Debbie Montjean5, Pierre Boyer5. 1. Service de Médecine et Biologie de la Reproduction, Hôpital Saint Joseph, 13008, Marseille, France. beltran_any@yahoo.com. 2. Département de Santé Publique et Maladies Chroniques, Aix-Marseille Université, Faculté de médecine, Unité de recherche EA 3279, 13005, Marseille, France. beltran_any@yahoo.com. 3. Département de Santé Publique et Maladies Chroniques, Aix-Marseille Université, Faculté de médecine, Unité de recherche EA 3279, 13005, Marseille, France. 4. Service d'information médicale, Assistance Publique Hôpitaux de Marseille, 13009, Marseille, France. 5. Service de Médecine et Biologie de la Reproduction, Hôpital Saint Joseph, 13008, Marseille, France.
Abstract
PURPOSE: The study aims to describe the newborn health parameters of the 50 first children conceived after autologous oocyte vitrification in France. METHODS: The 50 children born after autologous oocyte vitrification/warming cycle (VAO children) have been retrospectively compared with 364 children conceived by micromanipulation using freshly recovered non-vitrified oocytes (ICSI children). Children included in the study were born between 2011 and 2015. Maternal characteristics (age, body mass index, smoking habits), obstetric outcomes (diabetes, hypertension, placenta previa, parity, mode of delivery), and perinatal outcome (twinning, sex, birth weight, macrosomia, birth defects) were analyzed. The generalized estimating equation for correlated data was performed to evaluate perinatal outcomes and caesarean section. RESULTS: No statistically significant difference was found between VAO children and ICSI children, even after adjusting confounding factors (low birth weigh odds ratio (OR) 0.8, 95 % confident interval (CI) 0.3-2.2, adjusted (AOR) 0.5, 95 % CI 0.2-1.7; large for gestational age OR 1.5, 95 % CI 0.3-7.0, AOR 1.6, 95 % CI 0.3-7.5; birth defects OR 0.4, 95 % CI 0.1-3.2, AOR 0.5, 95 % CI 0.1-3.7; caesarean section OR 1.8, 95 % CI 0.9-3.4, AOR 1.8, 95 % CI 0.9-3.7). CONCLUSIONS: According to our results, newborn health parameters of children conceived in our center by micromanipulation using vitrified/warmed autologous oocytes seem not to be different from children born after micromanipulation on freshly recovered oocytes.
PURPOSE: The study aims to describe the newborn health parameters of the 50 first children conceived after autologous oocyte vitrification in France. METHODS: The 50 children born after autologous oocyte vitrification/warming cycle (VAO children) have been retrospectively compared with 364 children conceived by micromanipulation using freshly recovered non-vitrified oocytes (ICSI children). Children included in the study were born between 2011 and 2015. Maternal characteristics (age, body mass index, smoking habits), obstetric outcomes (diabetes, hypertension, placenta previa, parity, mode of delivery), and perinatal outcome (twinning, sex, birth weight, macrosomia, birth defects) were analyzed. The generalized estimating equation for correlated data was performed to evaluate perinatal outcomes and caesarean section. RESULTS: No statistically significant difference was found between VAO children and ICSI children, even after adjusting confounding factors (low birth weigh odds ratio (OR) 0.8, 95 % confident interval (CI) 0.3-2.2, adjusted (AOR) 0.5, 95 % CI 0.2-1.7; large for gestational age OR 1.5, 95 % CI 0.3-7.0, AOR 1.6, 95 % CI 0.3-7.5; birth defects OR 0.4, 95 % CI 0.1-3.2, AOR 0.5, 95 % CI 0.1-3.7; caesarean section OR 1.8, 95 % CI 0.9-3.4, AOR 1.8, 95 % CI 0.9-3.7). CONCLUSIONS: According to our results, newborn health parameters of children conceived in our center by micromanipulation using vitrified/warmed autologous oocytes seem not to be different from children born after micromanipulation on freshly recovered oocytes.
Entities:
Keywords:
Autologous oocytes; Children health; Retrospective study; Vitrification
Authors: L Meddeb; M Boyer; V Pauly; P Tourame; B Rossin; B Pfister; P Boyer Journal: Rev Epidemiol Sante Publique Date: 2011-03-22 Impact factor: 1.019
Authors: S Pelkonen; R Koivunen; M Gissler; S Nuojua-Huttunen; A-M Suikkari; C Hydén-Granskog; H Martikainen; A Tiitinen; A-L Hartikainen Journal: Hum Reprod Date: 2010-02-02 Impact factor: 6.918
Authors: Joyce Harper; M Cristina Magli; Kersti Lundin; Christopher L R Barratt; Daniel Brison Journal: Hum Reprod Date: 2011-12-12 Impact factor: 6.918